Partner with Perthera
Figure: Patients who received highly ranked, matched treatment recommendations through the Perthera Platform lived significantly longer than patients who were not treated with matched treatment recommendations (Pishvaian et al. Lancet Oncology 2020)
to Advance Clinical Research in High Impact Journals
The Platform’s utility has been published in high impact journals, such as The Lancet Oncology and the American Association of Clinical Research Journal, to significantly improve patient survival rates and advance clinical research and publication efforts for physicians.
Contact us to find out how you can start using Perthera’s Precision Medicine Platform for your patients today!
